A team of three UW-Madison researchers will serve as co-investigators on a research project that will explore new treatments for neuroendocrine cancers. Herb Chen, MD, professor with the Department of Surgery, Shaoqin “Sarah” Gong, PhD, associate professor of Biomedical Engineering, and Renata Jaskula-Sztul, PhD, an associate scientist in Dr. Chen’s lab, will test a new anti-cancer drug and its effectiveness against carcinoid cancer cells. The drug will be delivered using nanotechnology as a way to package the drug to maximize effectiveness and minimize side effects.
The project will be funded through the Caring for Carcinoid Foundation, an organization that funds research grants to leading scientists to help discover cures for neuroendocrine cancers and support patients, families and caregivers affected by the disease. The UW-Madison research team’s proposal was one of two projects chosen to receive support through CFCF’s current round of funding. The two projects were chosen through a peer-reviewed selection process from proposals solicited from the American Association of Cancer Research’s 34,000 members.